Conway Edward M, Zwerts Femke, Van Eygen Veerle, DeVriese Astrid, Nagai Nobuo, Luo Wei, Collen Désiré
Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, University of Leuven, Gasthuisberg O&N, 9th Floor, Herestraat 49, B-3000 Leuven, Belgium.
Am J Pathol. 2003 Sep;163(3):935-46. doi: 10.1016/S0002-9440(10)63453-0.
Approaches to regulating angiogenesis in the brain, which may diminish parenchymal damage after stroke, are lacking. Survivin, the inhibitor of apoptosis protein, is up-regulated in vitro in vascular endothelial cells by angiogenic factors, including vascular endothelial cell growth factor (VEGF). To evaluate the in vivo role of survivin in the brain in response to hypoxia/ischemia, we used a mouse model of stroke and show that 2 days after permanent middle cerebral artery occlusion, survivin is uniquely expressed by microvessels that form in the peri-infarct and infarct regions. The extent of vascularization of the infarct is dependent on expression of survivin, since vessel density is significantly reduced in mice with heterozygous deficiency of the survivin gene (survivin+/- mice), even though infarct sizes were not different. Hypoxia alone induces survivin expression in the brain, by cultured endothelial cells and by embryonic stem cells, but this response is at least partially independent of VEGF, hypoxia inducible factor 1alpha, or placental growth factor. Delineating the spatiotemporal pattern of expression of survivin after stroke, and the molecular mechanisms by which this is regulated, may provide novel approaches to therapeutically optimize angiogenesis in a variety of ischemic disorders.
目前缺乏调控脑内血管生成的方法,而这种方法可能会减少中风后的实质损伤。凋亡抑制蛋白Survivin在体外可被包括血管内皮生长因子(VEGF)在内的血管生成因子上调表达于血管内皮细胞。为了评估Survivin在脑内对缺氧/缺血反应中的体内作用,我们使用了一种中风小鼠模型,并发现永久性大脑中动脉闭塞2天后,Survivin在梗死灶周围和梗死区域形成的微血管中特异性表达。梗死灶的血管化程度取决于Survivin的表达,因为在Survivin基因杂合缺失的小鼠(Survivin+/-小鼠)中,血管密度显著降低,尽管梗死灶大小并无差异。单独缺氧可诱导培养的内皮细胞和胚胎干细胞在脑内表达Survivin,但这种反应至少部分独立于VEGF、缺氧诱导因子1α或胎盘生长因子。描绘中风后Survivin表达的时空模式及其调控的分子机制,可能为治疗性优化各种缺血性疾病中的血管生成提供新方法。